EUVIMEDEUVIMED entdecken
Multizentrische StudieLeitlinieOpen Access · CC BY-NC-ND 4.0

Adherence to United European Gastroenterology Guidelines on Diagnosis and Therapy of Immunoglobulin‐G4‐Related Digestive Disease

Miroslav Vujasinovic iD, Marco Lanzillotta iD, Emma L Culver iD, Vinciane Rebours iD, Joost P H Drenth iD, Milica Stojkovic Lalosevic, Jens Vikse, Natalya Gubergrits, Michael Hirth iD, Vincenzo Cardinale, Rodrigo Vieira Motta, Emanuel Della-Torre iD und 11 weitere

United European Gastroenterology Journal · 2025

DOI: 10.1002/ueg2.70081 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift United European Gastroenterology Journal, 2025. Verfasst von Miroslav Vujasinovic und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Upper Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Guideline Adherence, Immunoglobulin G4-Related Disease, Gastroenterology, Immunoglobulin G. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

United European Gastroenterology (UEG) Guidelines on immunoglobulin G4 (IgG4)‐related digestive disease provides evidence‐based recommendations for the diagnosis and management of IgG4‐related digestive disease. The aim of this study is to evaluate the adherence to recommendations of this IgG4 guideline across centers in Europe. Patients and methods Questionnaire‐based data related to organ involvement, diagnosis, treatment and follow‐up of newly diagnosed patients with IgG4‐related digestive diseases over a 3‐year period, were collected from 14 centers in 11 European countries.

Results

One hundred and ninety‐nine patients (76% males) were included. Median age at diagnosis was 64 years. Most of the patients had concomitant pancreatic and biliary tree involvement (46%), followed by isolated pancreatic involvement (33.5%), isolated biliary tree involvement (18.5%), esophageal involvement (1.5%) or bowel (0.5%) involvement. Most of the patients (64%) underwent a combination of computed tomography and magnetic resonance imaging at diagnosis. Among the 158 autoimmune pancreatitis patients with or without concomitant bile duct involvement, treatment was performed according to guidelines in 115 patients (73%; moderate adherence). Follow‐up assessment was performed between 2 and 4 weeks in 75 patients (47%, partial adherence). Among 37 patients with liver‐ or biliary tree involvement, 29 patients were treated according to guidelines (78%; full adherence). In the follow‐up of patients with isolated liver‐ or biliary tree involvement, we observed moderate adherence in 21 (57%). Disease monitoring for activity and damage using the IgG4 responder activity index was utilized in only 3/14 centers (poor adherence).

Conclusions

IgG4‐related digestive disease is restricted to the pancreas and bile ducts in the majority of patients. Even in specialist centers with an interest in IgG4‐related digestive disease, UEG guideline treatment adherence was moderate, follow‐up at 2–4 weeks was only partial, and monitoring for disease activity was poor. These findings highlight the need for ongoing education and improved adherence to monitoring among healthcare providers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Guideline AdherenceImmunoglobulin G4-Related DiseaseGastroenterologyImmunoglobulin GDigestive System DiseasesAutoimmune PancreatitisHumansMaleFemaleMiddle AgedEuropeAgedAdultPractice Guidelines as TopicSurveys and QuestionnairesAged, 80 and overTomography, X-Ray Computed

Stichwörter der Autor:innen

IgG4‐related cholangitisIgG4‐related digestive diseaseUnited European Gastroenterologyadherenceautoimmune pancreatitisbile ductsguidelineimmunoglobulin G4pancreas

Substanzen

Immunoglobulin G

Autor:innen und Institutionen

  • Department of Upper Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden.
  • Università Vita-Salute San Raffaele, Milan, Italy.
  • Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Translational Gastroenterology and Liver Unit, John Radcliffe Hospital, Oxford, UK.
  • Nuffield Department of Medicine, University of Oxford, Oxford, UK.

ORCID-Profile: Miroslav Vujasinovic, Marco Lanzillotta, Emma L Culver, Vinciane Rebours, Joost P H Drenth, Michael Hirth, Emanuel Della-Torre, Nicole Sciberras, Marcello Maida, Frank Lammert, Jens Brøndum Frøkjær, Gabriele Capurso, J-Matthias Löhr

Zitieren

APA

Vujasinovic, M., Lanzillotta, M., Culver, E. L., Rebours, V., Drenth, J. P. H., Stojkovic Lalosevic, M., Vikse, J., Gubergrits, N., Hirth, M., Cardinale, V., Motta, R. V., Della-Torre, E., Sciberras, N., Maida, M., Trikola, A., Lammert, F., Descourvières, C., Ponsioen, C., Frøkjær, J. B., …, & Löhr, J. M. (2025). Adherence to United European Gastroenterology Guidelines on Diagnosis and Therapy of Immunoglobulin‐G4‐Related Digestive Disease. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70081

Vancouver

Vujasinovic M, Lanzillotta M, Culver EL, Rebours V, Drenth JPH, Stojkovic Lalosevic M, et al. Adherence to United European Gastroenterology Guidelines on Diagnosis and Therapy of Immunoglobulin‐G4‐Related Digestive Disease. United European Gastroenterology Journal. 2025. doi:10.1002/ueg2.70081

BibTeX
@article{Vujasinovic2025,
  author = {Vujasinovic, Miroslav and Lanzillotta, Marco and Culver, Emma L and Rebours, Vinciane and Drenth, Joost P H and Stojkovic Lalosevic, Milica and Vikse, Jens and Gubergrits, Natalya and Hirth, Michael and Cardinale, Vincenzo and Motta, Rodrigo Vieira and Della-Torre, Emanuel and Sciberras, Nicole and Maida, Marcello and Trikola, Artemis and Lammert, Frank and Descourvières, Clemence and Ponsioen, Cyriel and Frøkjær, Jens Brøndum and Schneider, Alexander and Alvaro, Domenico and Capurso, Gabriele and Löhr, J-Matthias},
  title = {Adherence to United European Gastroenterology Guidelines on Diagnosis and Therapy of Immunoglobulin‐G4‐Related Digestive Disease},
  journal = {United European Gastroenterology Journal},
  year = {2025},
  doi = {10.1002/ueg2.70081}
}
Kostenlos starten →